CANCER ANTIBODIES, INC.
LONGWOOD, FLORIDA

CANCER ANTIBODIES, INC. is a nonprofit organization based in Longwood, Florida, dedicated to advancing cancer research and development through innovative antibody therapies. Incorporated on July 18, 2017, under the filing number N17000007437 with Seminole County, the company maintains its mailing address at 519 SABAL TRAIL CIR, LONGWOOD, FL, 32779. As a recognized 501(c)(3) charity in the United States, donations to CANCER ANTIBODIES, INC. are tax-deductible according to U.S. law, which underscores its commitment to leveraging public support for advancing cancer treatments. The company operates with patent-pending technology and is managed by a team of experienced professionals. Elliot Davis serves as the President, with Sharon D. Davis and Joseph J. Davis acting as Vice President and Chief Technical Officer (CTO), respectively. Together, they guide the organization towards its mission of harnessing antibody science to combat cancer. CANCER ANTIBODIES, INC. relies on public contributions to further its research initiatives. The team acknowledges that, like the body's immune response which requires a multitude of antibodies to make an impactful difference, advancing their scientific breakthroughs depends significantly on collective support from donors and supporters. The organization’s efforts are detailed on their website, hosted by WebStuff, at cancerantibodies.com. Mark your calendars to note that the company last filed its annual report for the year 2025 on January 4, underscoring its ongoing transparency and commitment to regulatory compliance as verified through its Federal Employer Identification Number (FEIN): 82-2196115.